| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
4,355 |
3,801 |
$580K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
6,052 |
5,187 |
$531K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,279 |
1,156 |
$238K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,389 |
1,282 |
$164K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,529 |
2,335 |
$118K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
294 |
277 |
$25K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
118 |
96 |
$3K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
119 |
100 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
80 |
76 |
$1K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
56 |
50 |
$972.60 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
16 |
13 |
$338.16 |
| 80053 |
Comprehensive metabolic panel |
17 |
13 |
$169.52 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
15 |
13 |
$72.50 |
| 36415 |
Collection of venous blood by venipuncture |
233 |
202 |
$72.00 |
| 81002 |
|
32 |
26 |
$66.10 |